|
|
K Furukawa, M Mori, N Ohta, H Ikeda, H Shida, K Furukawa, H Shiku
J Clin Invest. 1994;
94(5):1830
doi:10.1172/JCI117532
Abstract |
Full text
| PDF

S
hort-term culture of peripheral blood mononuclear cells (PBMC) derived from patients with human T cell lymphotropic virus type I-associated myelopathy (HAM)/tropical spastic paraparesis resulted in dominance by DR+ activated CD8+ T cells. Variations in the T cell receptor (TCR) V alpha and V beta chains in these cells were analyzed, and in all 10 patients examined, 2-3 V gene families were dominant in both TCR V alpha and V beta. In five patients we examined, cultured lymphocytes contained cytotoxic lymphocytes for p40tax (patients HAM2, 3, 7, and 8) or env protein (patient HAM4) of human T lymphotropic virus type I. In patients HAM2 and HAM8, cultured lymphocytes contained a large proportion of V beta 8+ CD8+ and/or V beta 12+ CD8+ cells. The sequence of V beta 8+ and V beta 12+ cDNA revealed that they were oligoclonal with identical or similar sequences in each patient. Elimination experiments with monoclonal antibodies for TCR V beta 8 and V beta 12 showed that they were CD8+ cytotoxic T lymphocytes (CTL) for p40tax. In addition, flow cytometry and sequencing analysis of uncultured PBMC revealed that in HAM2, V beta 8+ CTL and their precursors account for 7% and V beta 12+ CTL and their precursors account for 18% of total CD8+ cells. This indicates the presence of two markedly expanded clones in vivo. No common dominant TCR V alpha or V beta were observed among 10 HAM patients analyzed.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(6)
| Title and authors |
Publication |
Year |
Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders
Tomohiro Kozako, Masaki Akimoto, Shingo Toji, Yohann White, Susumu Suzuki, Takehiro Arima, Yukio Suruga, Kakushi Matsushita, Hiroshi Shimeno, Shinji Soeda, Ryuji Kubota, Shuji Izumo, Kimiharu Uozumi, Naomichi Arima
|
J. Med. Virol.
|
2011 |
Interferon-?1a therapy in human T-lymphotropic virus type I-associated neurologic disease
Unsong Oh, Yoshihisa Yamano, Carlos A. Mora, Joan Ohayon, Francesca Bagnato, John A. Butman, James Dambrosia, Thomas P. Leist, Henry McFarland, Steven Jacobson
|
Ann Neurol.
|
2005 |
Immunopathogenesis of Human T Cell Lymphotropic Virus Type I–Associated Neurologic Disease
Steven Jacobson
|
J INFECT DIS
|
2002 |
The immune response to HTLV-I
Charles RM Bangham
|
Current Opinion in Immunology
|
2000 |
Semiquantitative analysis of residual disease in patients treated for adult T-cell leukaemia/lymphoma (ATLL)
India Leclercq, Franck Mortreux, Franck Morschhauser, Patrick Duthilleul, Claude Desgranges, Antoine Gessain, Marielle Cavrois, Jean-Paul Vernant, Olivier Hermine, Eric Wattel
|
Br J Haematol
|
1999 |
Expansion of Clonotypic T-Cell Populations in the Peripheral Blood of Asymptomatic Gran Chaco Amerindians Infected With HTLV-IIB
Jayne L. Love, Carmine C. Marchioli, Syamalima Dube, Virginia Bryz-Gornia, Thomas P. Loughran, Jordan B. Glaser, Eduardo Esteban, Leonardo Feldman, Jorge F. Ferrer, Bernard J. Poiesz
|
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
|
1998 |
|